Evotec (EVO) vs Phathom Pharmaceuticals (PHAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Phathom Pharmaceuticals (PHAT) has outperformed Evotec (EVO) over the past year, losing 37.2% versus a loss of 58.9%. Over five years, PHAT leads with a -79.1% price change compared with -92.9% for EVO. Evotec is the larger company by market cap ($572.2 million vs $550.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EVO | PHAT |
|---|---|---|
| Share price | $1.61 | $6.81 |
| Market cap | $572.18M | $550.94M |
| 1-day change | -1.23% | +0.44% |
| YTD return | -47.73% | -58.95% |
| 1-year return | -58.93% | -37.18% |
| 5-year return | -92.87% | -79.05% |
| Forward P/E | — | 6.33 |
| EPS (TTM) | $-0.64 | $-1.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.27 | $18.31 |
| 52-week low | $1.50 | $6.52 |
| Distance from 52-week high | -62.30% | -62.81% |
| Average volume | 102.81K | 1.39M |
| Shares outstanding | 355.39M | 80.90M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PHAT has outperformed EVO by 21.8 percentage points over the past year.
EVO vs PHAT FAQ
Which is bigger, Evotec or Phathom Pharmaceuticals?
Evotec (EVO) is larger, with a market capitalization of $572.18M compared with $550.94M for Phathom Pharmaceuticals (PHAT).
Which stock has performed better over the past year, EVO or PHAT?
PHAT returned -37.18% over the past 12 months, compared with -58.93% for EVO (price return, excluding dividends). Past performance does not predict future results.
Are Evotec and Phathom Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.